Literature DB >> 10077573

Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression.

P Sanz1, B Moss.   

Abstract

Vaccinia virus early, intermediate, and late stage genes are sequentially transcribed by the viral RNA polymerase within the cytoplasm of infected cells. We found that the 34- and 45-kDa polypeptides encoded by vaccinia virus ORFs A8R and A23R, respectively, were necessary to reconstitute transcription of a template with an intermediate stage promoter. Coexpression of the A8R and A23R genes in Escherichia coli was required for in vitro activity. In addition, the two polypeptides copurified, indicating their association as protein subunits of a vaccinia virus intermediate transcription factor. This factor, which we named VITF-3, complemented three viral proteins-namely, the RNA polymerase, capping enzyme, and a 30-kDa protein called VITF-1 that is also a subunit of the RNA polymerase-and an unidentified cell factor called VITF-2. Expression of the A8R and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo. The vaccinia virus A8R and A23R genes are highly conserved among vertebrate poxviruses, but no other viral or cellular homologs were identified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077573      PMCID: PMC15831          DOI: 10.1073/pnas.96.6.2692

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  The complete DNA sequence of vaccinia virus.

Authors:  S J Goebel; G P Johnson; M E Perkus; S W Davis; J P Winslow; E Paoletti
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

2.  Early transcription factor subunits are encoded by vaccinia virus late genes.

Authors:  P D Gershon; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.

Authors:  J G Keck; C J Baldick; B Moss
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

4.  Structure of vaccinia virus late promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

5.  Structure of vaccinia virus early promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

6.  Identification of factors specific for transcription of the late class of vaccinia virus genes.

Authors:  C F Wright; B Moss
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Vaccinia virus gene encoding a component of the viral early transcription factor.

Authors:  S S Broyles; B S Fesler
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  A vaccinia virus late transcription factor with biochemical and molecular identity to a human cellular protein.

Authors:  S K Gunasinghe; A E Hubbs; C F Wright
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

9.  Purification of a factor required for transcription of vaccinia virus early genes.

Authors:  S S Broyles; L Yuen; S Shuman; B Moss
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

10.  Derepression of a novel class of vaccinia virus genes upon DNA replication.

Authors:  J C Vos; H G Stunnenberg
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  18 in total

1.  Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase.

Authors:  G R Kovacs; N Vasilakis; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.

Authors:  W W Yeh; B Moss; E J Wolffe
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Reverse genetics analysis of poxvirus intermediate transcription factors.

Authors:  Robin D Warren; Catherine A Cotter; Bernard Moss
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

5.  Genome-wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

6.  Diversity in the acute CD8 T cell response to vaccinia virus in humans.

Authors:  Lichen Jing; Tiana M Chong; Christopher L McClurkan; Jay Huang; Brian T Story; David M Koelle
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

7.  Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.

Authors:  Bruce A Knutson; Xu Liu; Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism.

Authors:  Youdong Pan; Tian Tian; Chang Ook Park; Serena Y Lofftus; Shenglin Mei; Xing Liu; Chi Luo; John T O'Malley; Ahmed Gehad; Jessica E Teague; Sherrie J Divito; Robert Fuhlbrigge; Pere Puigserver; James G Krueger; Gökhan S Hotamisligil; Rachael A Clark; Thomas S Kupper
Journal:  Nature       Date:  2017-02-20       Impact factor: 49.962

9.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

10.  Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase.

Authors:  Nouhou Ibrahim; April Wicklund; Augusta Jamin; Matthew S Wiebe
Journal:  Virology       Date:  2013-07-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.